Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (461-470 of 489) with videos related to

Pageof 49
Sort By:
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
Neuron|April 9, 2013
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Oscar Harari, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurobiology of Aging|January 21, 2014
Missense variant in TREML2 protects against Alzheimer's diseaseBruno A Benitez, Sheng Chih Jin, Rita Guerreiro, et al.
Revue Neurologique|September 11, 2013
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trialS M Mills, J Mallmann, A M Santacruz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Brain Communications|November 9, 2023
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's diseaseJorge J Llibre-Guerra, Leonardo Iaccarino, Dean Coble, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Pageof 49

Showing results (461-470 of 489) with videos related to

Sort By:
Pageof 49
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
Neuron|April 9, 2013
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Oscar Harari, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurobiology of Aging|January 21, 2014
Missense variant in TREML2 protects against Alzheimer's diseaseBruno A Benitez, Sheng Chih Jin, Rita Guerreiro, et al.
Revue Neurologique|September 11, 2013
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trialS M Mills, J Mallmann, A M Santacruz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Brain Communications|November 9, 2023
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's diseaseJorge J Llibre-Guerra, Leonardo Iaccarino, Dean Coble, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Pageof 49